Condition

Lipohypertrophy

ClinicalTrials.gov condition label

Clinical trials13
Recruiting1
Common interventions16
Lead sponsors shown11

Clinical trials

13 shown
The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic ControlNCT05377268 · 2023-03-01
RECRUITING
Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy RiskNCT07561086 · 2025-06-01
COMPLETED
De-tensioning Patch, in Subjects With Type 1 Diabetes and LipohypertrophyNCT06025513 · 2024-02-16
COMPLETED
Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LHNCT06074965 · 2022-10-05
COMPLETED
The Visceral Adiposity Measurement and Observation StudyNCT05383456 · 2022-04-18
COMPLETED
Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp TechniqueNCT03229850 · 2021-02-01
WITHDRAWN
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes MellitusNCT04120974 · 2019-10-01
COMPLETED
Effects of Semaglutide in HIV-Associated LipohypertrophyNCT04019197 · 2019-05-16
ACTIVE_NOT_RECRUITING
Lipohypertrophy Monitoring StudyNCT04659330 · 2018-06-01
COMPLETED
Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 DiabetesNCT03669770 · 2017-09-22
COMPLETED
Glucose Variability in Subclinical HypertrophyNCT02748434 · 2016-10-01
TERMINATED
Ultrasound Detection and Characterization of Subclinical Hypertrophy in DiabetesNCT02348099 · 2015-03-01
TERMINATED
Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With LipohypertrophyNCT01420523 · 2011-12-01
TERMINATED

Trial status mix

COMPLETED7
TERMINATED3
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1

Phase mix

NA8
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.